Genome-wide analysis of epigenetics involved in progression of overt diabetic nephropathy
Project/Area Number |
24790854
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Kidney internal medicine
|
Research Institution | Iwate Medical University |
Principal Investigator |
|
Project Period (FY) |
2012-04-01 – 2015-03-31
|
Project Status |
Completed (Fiscal Year 2014)
|
Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2014: ¥910,000 (Direct Cost: ¥700,000、Indirect Cost: ¥210,000)
Fiscal Year 2013: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Keywords | 糖尿病性腎症 / エピジェネティクス / 腎疾患 / 腎臓学 / 糖尿病 / メタボリックシンドローム / 血管内皮細胞 |
Outline of Final Research Achievements |
The metabolic syndrome is characterized by abdominal obesity, dyslipidemia, hypertension and hyperglycemia. The strength of hyperglycemia condition and a period are conserved in cells by epigenetic changes as “metabolic memory”. In this study, metabolic syndrome model rats were fed on a standard diet for one year three months and the epigenetic changes which induce kidney disease were analyzed by genome-wide DNA methylation states in glomerular vascular endothelial cells. As a result, about 2,000 genes, which decreased DNA methylation at gene promoters by metabolic syndrome, were found as a candidate. This screen revealed 11 genes that were concerned with an inflammation and 6 genes that were concerned formation of angiogenetic and glomerular vascular endothelial cells.
|
Report
(4 results)
Research Products
(4 results)